{'name': u'\uff1a\u4f59\u9732\u5c71', 'title': u'\uff1a\u526f\u6559\u6388', 'photo': u'http://mypage.zju.edu.cn/attachments/81/1210110936-294095129.jpg', 'pos': './mypage.zju.edu.cn/yuls', 'intro': [u'\n\t\t', u'\n\t\t\t\n            ', u'\u4e2a\u4eba\u7b80\u4ecb', u'\n\t\t\t', u'\n\t\t\t', u'\u4f59\u9732\u5c71\u535a\u58eb\uff0c\u526f\u6559\u6388\uff0c\u535a\u58eb\u751f\u5bfc\u5e08\u30022000\u5e74\u6bd5\u4e1a\u4e8e\u6d59\u6c5f\u5927\u5b66\u836f\u5b66\u9662\u836f\u5b66\u4e13\u4e1a\u83b7\u5f97\u5b66\u58eb\u5b66\u4f4d\uff0c2005\u5e74\u5728\u6d59\u6c5f\u5927\u5b66\u83b7\u5f97\u533b\u5b66\u535a\u58eb\u5b66\u4f4d\uff0c2005\u5e746\u6708\u81f32007\u5e749\u6708\u5728\u6d59\u6c5f\u5927\u5b66\u4ece\u4e8b\u535a\u58eb\u540e\u7814\u7a76\u5de5\u4f5c\uff0c2007\u5e749\u6708\u81f3\u4eca\u5728\u6d59\u6c5f\u5927\u5b66\u836f\u5b66\u9662\u4efb\u6559\uff0c\u526f\u6559\u6388\u804c\u79f0\uff0c2011\u5e749\u6708\uff0d2012\u5e749\u6708\u5728\u7f8e\u56fd\u5339\u5179\u5821\u5927\u5b66\u836f\u5b66\u9662\u505a\u8bbf\u95ee\u5b66\u8005\u3002\u4ece\u4e8b\u836f\u7269\u4ee3\u8c22\u9176\u7684\u8868\u8fbe\u8c03\u63a7\u3001\u624b\u6027\u836f\u7269\u5206\u6790\u548c\u4ee3\u8c22\u3001\u4e34\u5e8a\u524d\u836f\u7269\u4ee3\u8c22\u52a8\u529b\u5b66\u76f8\u5173\u7814\u7a76\u3002', u'\r\n', u'\u5df2\u53d1\u8868\u5b66\u672f\u8bba\u658760\u591a\u7bc7\uff0c\u5176\u4e2d\u4ee5\u7b2c\u4e00\u4f5c\u8005\u548c\u901a\u8baf\u4f5c\u8005\u53d1\u8868SCI\u6536\u5f55\u8bba\u658725\u7bc7\uff0c\u53c2\u7f16\u8457\u4f5c10\u90e8\u3002\u4e3b\u6301\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d12\u9879\uff0c\u56fd\u5bb6\u201c\u5341\u4e00\u4e94\u201d\u91cd\u5927\u65b0\u836f\u521b\u5236\u5b50\u8bfe\u98983\u9879\uff0c973\u5b50\u8bfe\u98981\u9879\uff0c\u4e2d\u56fd\u535a\u58eb\u540e\u57fa\u91d11\u9879\uff0c863\u6d77\u6d0b\u4e13\u9879\u5b50\u8bfe\u98981\u9879\uff0c\u6d59\u6c5f\u7701\u81ea\u7136\u79d1\u5b66\u57fa\u91d1\u9879\u76ee1\u9879\uff0c\u94b1\u6c5f\u4eba\u624d\u9879\u76ee1\u9879\uff0c\u4ee5\u7b2c\u4e8c\u5408\u4f5c\u8005\u5b8c\u6210\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d12\u9879\u3002\u8d1f\u8d23\u591a\u9879\u4f01\u4e1a\u5408\u4f5c\u9879\u76ee\u7814\u7a76\u3002\u83b7\u5f97\u6d59\u6c5f\u7701\u79d1\u5b66\u6280\u672f\u5956\u4e8c\u7b49\u59562\u9879\uff08\u6392\u540d2\u548c3\uff09\u3002', u'\r\n', u'\u73b0\u4e3aInternational Society for the Study of Xenobiotics (ISSX)\u3001\u4e2d\u56fd\u836f\u5b66\u4f1a\u836f\u7269\u4ee3\u8c22\u4e13\u4e1a\u59d4\u5458\u4f1a\u3001\u4e2d\u56fd\u836f\u7406\u5b66\u4f1a\u836f\u7269\u6bd2\u7406\u5b66\u4e13\u4e1a\u59d4\u5458\u4f1a\u4f1a\u5458\uff0c\u6d59\u6c5f\u7701\u836f\u5b66\u4f1a\u836f\u7269\u5206\u6790\u4e13\u4e1a\u59d4\u5458\u4f1a\u79d8\u4e66\u3002', u'\r\n', u'\xa0', u'\r\n', u'\xa0', u'\u8fd1\u671f\u7814\u7a76\u8bba\u6587\uff1a', u'\r\n', u'1.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'ZT Wang,\xa0SJ Wang,\xa0MM Huang,\xa0HH Hu,\xa0LS Yu*,\xa0S Zeng. Characterizing the Effect of Cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 Genetic Polymorphisms on Stereoselective N-demethylation of Fluoxetine. Chirality,\xa02014,26: 166-173.', u'\r\n', u'2.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'LS Yu, JB Pu, MJ Zuo, X Zhang, Y Cao, S Chen, Y Lou, Q Zhou, HH Hu, HD Jiang, JZ Chen, S Zeng. Hepatic Glucuronidation of Isoneochamaejasmin A from the Traditional Chinese Medicine Stellera Chamaejasme L. Root. Drug Metab Dispos, 2014, 42: 1-9.', u'\r\n', u'3.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'YT Zhou,\xa0LS Yu, S Zeng, YW Huang, HM Xu, Q Zhou. Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management. Ther Clin Risk Manag. 2014;10:17-26.', u'\r\n', u'4.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'HH Hu, YC Bian, Y Liu, R Sheng, HD Jiang,\xa0LS Yu\xa0*, YZ Hu,\xa0S Zeng\xa0*. Evaluation of blood-brain barrier and blood-cerebrospinal fluid barrier permeability of 2-phenoxy-indan-1-one derivatives using in vitro cell models. Int J Pharm. 2014, 460(1-2):101-107.', u'\r\n', u'5.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'LS Yu, Q Shen, Q Zhou, HD Jiang, H Zhou,\xa0S Zeng. In vitro characterization of ABC transporters involved in the absorption and distribution of liensinine and its analogs. J Ethnopharmacol, 2013, 150:485-491.', u'\r\n', u'6.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'LS Yu,\xa0', u'Y Jiang', u', L Wang, R Sheng, YZ Hu,\xa0S Zeng.Metabolism of BYZX in Human Liver Microsomes and Cytosol: Identification of the Metabolites and Metabolic Pathways of BYZX.\xa0PLoS One, 2013, 8: e59882.', u'\r\n', u'7.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'LS Yu, D Shi, LP Ma, Q Zhou,\xa0S Zeng. Influence of CYP2C8 polymorphisms on the hydroxylation metabolism of paclitaxel, repaglinide, and ibuprofen enantiomers in vitro. Biopharm Drug Dispos, 2013, 34(5):278-87.', u'\r\n', u'8.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'HH Hu, C Su, Y Jiang,\xa0LS Yu*, Y Liu, Y Tian, SY Xu, H Zhou, X He, HD Jiang, S Zeng*. Construction and application of double-transfected cells expressing the human transporter P-glycoprotein and cytochrome P450\xa03A4. Pharmazie, 2013 68: 816\u2013820.', u'\r\n', u'9.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'Shangguan S,\xa0Wang F,\xa0Liao Y,\xa0Yu H,\xa0Li J, Huang W,\xa0Hu H,\xa0Yu L,\xa0Hu Y,\xa0Sheng R. Design, synthesis and evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide derivatives as BACE-1 inhibitors. \xa0Molecules.\xa02013 Mar 20;18(3):3577-94.', u'\r\n', u'10.', u'\xa0\xa0\xa0\xa0 ', u'M Chen, Y Lou, Y Wu, Z Meng, L Li,\xa0L Yu, S Zeng, H Zhou, H Jiang. Characterization of in \xa0vivo and in vitro metabolites of furanodiene in rats by high performance liquid chromatography-electrospray ionization mass spectrometry and nuclear magnetic resonance spectra. J Pharm Biomed Anal. 2013 Dec;86:161-8.', u'\r\n', u'11.', u'\xa0\xa0\xa0\xa0 ', u'Q Shen, L Wang, H Zhou, HD Jiang,\xa0LS Yu *,\xa0S Zeng. Stereoselective binding of chiral drugs to plasma proteins. Acta Pharmacol Sin, 2013, 34(8):998-1006.', u'\r\n', u'12.', u'\xa0\xa0\xa0\xa0 ', u'CC Guo, Y Jiang, L Li, L Hong, YQ Wang, Q Shen, Y Lou, HH Hu, H Zhou,\xa0LS Yu*, Jiang HD, Zeng S*. Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of Dactylicapnos scandens in rats. J Pharm Biomed Anal, 2013, 74: 92-100.', u'\r\n', u'13.', u'\xa0\xa0\xa0\xa0 ', u'W Li, S Zeng,\xa0LS Yu, Q Zhou.\xa0Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management. Ther Clin Risk Manag, 2013, 9:259-271.', u'\r\n', u'14.', u'\xa0\xa0\xa0\xa0 ', u'LS Yu, SJ Wang, S Zeng.\xa0Chiral mobile phase additives in HPLC enantioseparations. Methods Mol Biol. 2013, 970: 221-231.', u'\r\n', u'15.', u'\xa0\xa0\xa0\xa0 ', u'\u5f90\u806a,\xa0\u5f90\u601d\u4e91,\xa0\u80e1\u6d77\u7ea2,\xa0\u4f59\u9732\u5c71,\xa0\u66fe\u82cf. CYP2B6\xa0\u4f53\u5916\u8bf1\u5bfc\u6d3b\u6027\u8bc4\u4ef7\u6a21\u578b\u7684\u5efa\u7acb\u53ca\u5176\u5728\u4e2d\u836f\u6d3b\u6027\u6210\u5206\u7b5b\u9009\u7684\u5e94\u7528.\xa0\u836f\u5b66\u5b66\u62a5, 2013, 48: 119\u2212124.', u'\r\n', u'16.', u'\xa0\xa0\xa0\xa0 ', u'\u82cf\u6668,\xa0\u4f59\u9732\u5c71*,\xa0\u59da\u5f64\u709c,\xa0\u66fe\u82cf.\xa0\u91cd\u7ec4\u5927\u9f20\u957f\u94fe\uff12-\u7f9f\u9178\u6c27\u5316\u9176\u7684\u514b\u9686\u4e0e\u8868\u8fbe.\xa0\u4e2d\u56fd\u836f\u5b66\u6742\u5fd7\uff0c2013, 48: 331-336.', u'\r\n', u'17.', u'\xa0\xa0\xa0\xa0 ', u'LS Yu, SJ Wang, HD Jiang, H Zhou,\xa0S Zeng. Simultaneous determination of fluoxetine and norfluoxetine enantiomers using isotope discrimination mass spectroscopy solution method and its application in the CYP2C9-mediated stereoselective interactions. J Chromatogr A, 2012, 1236: 97-104.', u'\r\n', u'18.', u'\xa0\xa0\xa0\xa0 ', u'L Wang, W Lu, Q Shen, S Wang, H Zhou,\xa0LS Yu*, SC Wang, HD Jiang, LC He, Zeng S. Simultaneous determination of imperatorin and its 2 metabolites in dog plasma by using liquid chromatography-tandem mass spectrometry', u'.', u'\xa0J Pharm Biomed Anal, 2012, 70: 640-646.', u'\r\n', u'19.', u'\xa0\xa0\xa0\xa0 ', u'XJ Wang , H Zhou, J Zheng, C Huang, W Liu ,\xa0LS Yu*, Zeng S. Identification and characterization of four process-related impurities in retigabine. J Pharm Biomed Anal, 2012, 71: 148-151.', u'\r\n', u'20.', u'\xa0\xa0\xa0\xa0 ', u'LS Yu, YJ Hong, L Li, YX Jin, MY Zeng, HL Jiang, S Zeng. Enantioselective drug-protein interaction between mexiletine and plasma protein. J Pharm Pharmcol, 2012, 64: 792-801.', u'\r\n', u'21.', u'\xa0\xa0\xa0\xa0 ', u'LS Yu, YP Jin, J Zhou, C Ye, JZ Wang, GY Hu,\xa0S Zeng. Simultaneous determination of diastereoisomeric and enantiomeric impurities in (1R, 3R)-1-(1,3-benzodioxol-5-yl)-2-(chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester a key intermediate of tadala\ufb01l by chiral high-performance liquid chromatography. Chirality, 2012, 24: 303-306.', u'\r\n', u'22.', u'\xa0\xa0\xa0\xa0 ', u'ZT Wang, SJ Wang, F Zhu, ZX Chen,\xa0LS Yu*,\xa0S Zeng. Determination of enantiomeric impurity in besifloxacin hydrochloride by chiral high-performance liquid chromatography with pre-column derivatization.\xa0', u'Chirality, 2012, 24: 526', u'-531.', u'\r\n', u'23.', u'\xa0\xa0\xa0\xa0 ', u'\u738b\u541b\u71d5\uff0c\u4f59\u9732\u5c71*\uff0c\u66fe\u82cf.\xa0\u4eba\u5b55\u70f7X\u53d7\u4f53\u4ecb\u5bfc\u7684UGT1A1\u62a5\u544a\u57fa\u56e0\u6a21\u578b\u7684\u5efa\u7acb\u53ca\u521d\u6b65\u5e94\u7528.\xa0\u4e2d\u56fd\u836f\u5b66\u6742\u5fd7, 2012, 47: 1105-1109.', u'\r\n', u'24.', u'\xa0\xa0\xa0\xa0 ', u'\u9a6c\u4e3d,\xa0\u4f59\u9732\u5c71,\xa0\u59da\u5f64\u709c.\xa0\u4ee5\u80fd\u529b\u57f9\u517b\u4e3a\u5bfc\u5411\u7684\u836f\u7269\u5206\u6790\u7efc\u5408\u8bbe\u8ba1\u6027\u5b9e\u9a8c\u7684\u8bbe\u7f6e\u4e0e\u5b9e\u8df5.\xa0\u6559\u80b2\u6559\u5b66\u8bba\u575b, 2012, 34: 75-78.', u'\r\n', u'25.', u'\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71,\xa0\u5434\u6c38\u6c5f,\xa0\u59da\u5f64\u709c,\xa0\u848b\u60e0\u5a23,\xa0\u66fe\u82cf.\u5168\u7a0b\u6559\u5b66\u8d28\u91cf\u8bc4\u4ef7\u548c\u63d0\u9ad8\u4f53\u7cfb\u7684\u6784\u5efa.\xa0\u4e2d\u56fd\u9ad8\u7b49\u533b\u5b66\u6559\u80b2, 2012, 11: 63-65.', u'\r\n', u'26.', u'\xa0\xa0\xa0\xa0 ', u'CC Guo, CN Yu, L Li, YQ Wang, SJ Wang, HH Hu, SY Xu,\xa0LS Yu, HD Jiang, S Zeng. Rapid determination of isocorydine in rat plasma and tissues using liquid chromatography-tandem mass spectrometry and its applications to pharmacokinetics and tissue distribution. Xenobiotica, 2012, 42: 466-476.', u'\r\n', u'27.', u'\xa0\xa0\xa0\xa0 ', u'Y Wang, HH Hu, H Pang, XY Zhou,\xa0LS Yu, LL Wang, C Liu, KN Guo, C Zhao, Q Liu, BH Zeng, H Tang, HT Shang, S Zeng, H Wei. Lentiviral transgenic microRNA-based shRNA suppressed mouse cytochromosome P450\xa03A\xa0(CYP3A) expression in a dose-dependent and inheritable manner. PLoS One, 2012, 7: e30560.', u'\r\n', u'28.', u'\xa0\xa0\xa0\xa0 ', u'LM Kong, MR Qian, HH Hu, SY Xu,\xa0LS Yu, HD Jiang, SQ Chen, S Zeng. Comparison of catalytical activity and stereoselectivity between the recombinant human cytochrome P450 2D6.1 and 2D6.10. Pharmazie, 2012, 67: 440-447.', u'\r\n', u'29.', u'\xa0\xa0\xa0\xa0 ', u'D Shi, YX Jin, YH Tang, HH Hu, SY Xu, LS Yu, HD Jiang, Zeng S. Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains. Acta Pharmacol Sin, 2012, 33: 710-716.', u'\r\n', u'30.', u'\xa0\xa0\xa0\xa0 ', u'CN Yu, XJ Chai,\xa0LS Yu, SQ Chen,\xa0S Zeng. Identification of novel pregnane X receptor activators from traditional Chinese medicines. J Ethnopharmacol, 2011, 136: 137-43.', u'\r\n', u'31.', u'\xa0\xa0\xa0\xa0 ', u'MX Meng,\xa0LS Yu*, TW Yao, R Sheng, YZ Hu,\xa0S Zeng. Development of a UPLC-MS/MS Method for Quantitative Determination of BYYT-25 in\xa0Rat Plasma and its Application to a Pharmacokinetic Study. J Chromatogr Sci, 2011, 49: 255-258.', u'\r\n', u'32.', u'\xa0\xa0\xa0\xa0 ', u'Y Lou, HH Hu, YQ Liu, QQ Yu, L Li, L Ping,\xa0LS Yu, HD Jiang, S Zeng. Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study. J Pharm Biomed Anal. 2011 Jul 15;55(5):1163-9.', u'\r\n', u'33.', u'\xa0\xa0\xa0\xa0 ', u'\u5218\u7476\uff0c\u6d2a\u5c9a\uff0c\u4f59\u9732\u5c71\uff0c\u848b\u60e0\u5a23\uff0c\u9648\u5efa\u5fe0\uff0c\u5b5f\u7434\uff0c\u9648\u67a2\u9752\uff0c\u66fe\u82cf.\xa0\u521b\u65b0\u836f\u7269\u8f6c\u5316\u7814\u7a76\u4e2dADME\xa0\u7684\u8bc4\u4ef7.\xa0\u836f\u5b66\u5b66\u62a5, 2011, 4: 19-29.', u'\r\n', u'34.', u'\xa0\xa0\xa0\xa0 ', u'\u94b1\u9e23\u84c9\uff0c\u9648\u9759\uff0c\u5218\u7476\uff0c\u4f59\u9732\u5c71\uff0c\u9648\u67a2\u9752\uff0c\u66fe\u82cf.\xa0\u4e0eCYPOR\u5171\u8868\u8fbeCYP2D6*1\u548c\xa0CYP2D6*10\u53ca\u5176\u4ee3\u8c22\u6d3b\u6027\u6bd4\u8f83.\xa0\u836f\u5b66\u5b66\u62a5, 2011, 4: 207-212.', u'\r\n', u'35.', u'\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71\uff0c\u59da\u5f64\u709c\uff0c\u66fe\u82cf.\xa0\u591a\u5143\u5316\u8003\u8bd5\u6a21\u5f0f\u5728\u836f\u7269\u5206\u6790\u7cbe\u54c1\u8bfe\u7a0b\u5efa\u8bbe\u4e2d\u7684\u5b9e\u8df5.\xa0\u836f\u5b66\u6559\u80b2, 2011, 27: 29-31.', u'\r\n', u'36.', u'\xa0\xa0\xa0\xa0 ', u'\u59da\u8273,\xa0\u5f20\u971e,\xa0\u5218\u7476,\xa0\u4f59\u9732\u5c71,\xa0\u848b\u60e0\u5a23,\xa0\u66fe\u82cf. RP-HPLC\u6cd5\u6d4b\u5b9a\u4eba\u5c3f\u82f7\u4e8c\u78f7\u9178\u8461\u919b\u9178\u8f6c\u79fb\u9176UGT1A3\u8f6c\u57fa\u56e0\u7ec6\u80de\u4e2d\u69f2\u76ae\u7d20.\xa0\u6d59\u6c5f\u5927\u5b66\u5b66\u62a5(\u533b\u5b66\u7248), 2011, 40: 7-11.', u'\r\n', u'\xa0', u'\r\n', u'\u53c2\u7f16\u8457\u4f5c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\r\n', u'1.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71.\xa0\u836f\u7269\u7684\u542b\u91cf\u6d4b\u5b9a.\xa0\u89c1\uff1a\u66fe\u82cf\u4e3b\u7f16\uff0c\u836f\u7269\u5206\u6790\u5b66\uff0c\u7b2c2\u7248\uff0c\u5317\u4eac\uff1a\u9ad8\u7b49\u6559\u80b2\u51fa\u7248\u793e\uff0c2014\u5e742\u6708.', u'\r\n', u'2.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'LS Yu. Chiral Separations methods and protocols (Chapter 13th). Gerhard KE Scriba Editor. Second Edition. Springer, 2013.', u'\r\n', u'3.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71.\xa0\u9ad8\u6548\u6db2\u76f8\u8272\u8c31\u6cd5\u548c\u6db2\u8d28\u8054\u7528\u6280\u672f\uff1b\u4f53\u5185\u836f\u7269\u5206\u6790\u5b9e\u9a8c.\xa0\u89c1\uff1a\u59da\u5f64\u709c\u4e3b\u7f16\uff0c\u4f53\u5185\u836f\u7269\u5206\u6790\uff0c\u7b2c\u4e00\u7248\uff0c\u676d\u5dde\uff1a\u6d59\u6c5f\u5927\u5b66\u51fa\u7248\u793e\uff0c2012\u5e746\u6708.', u'\r\n', u'4.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71.\xa0\u836f\u7269\u7684\u6742\u8d28\u68c0\u67e5.\xa0\u89c1\uff1a\u59da\u5f64\u709c\u4e3b\u7f16\uff0c\u836f\u7269\u5206\u6790\uff0c\u7b2c1\u7248\uff0c\u676d\u5dde\uff1a\u6d59\u6c5f\u5927\u5b66\u51fa\u7248\u793e\uff0c2011\u5e745\u6708.', u'\r\n', u'5.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71.\xa0\u836f\u7269\u7684\u6742\u8d28\u68c0\u67e5.\xa0\u89c1\uff1a\u59da\u5f64\u709c\u4e3b\u7f16\uff0c\u836f\u7269\u5206\u6790\u4e60\u9898\u4e0e\u8003\u8bd5\u6307\u5357\uff0c\u7b2c1\u7248\uff0c\u676d\u5dde\uff1a\u6d59\u6c5f\u5927\u5b66\u51fa\u7248\u793e\uff0c2011\u5e745\u6708.', u'\r\n', u'6.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71.\xa0\u82b3\u9178\u7c7b\u975e\u753e\u4f53\u6297\u708e\u836f\u7269\u7684\u5206\u6790.\xa0\u89c1\uff1a\u4e8e\u6cbb\u56fd\u4e3b\u7f16\uff0c\u836f\u7269\u5206\u6790\u5b66\u4e60\u6307\u5bfc\u4e0e\u4e60\u9898\u96c6\uff08\u672c\u79d1\u836f\u5b66\u914d\u6559\uff09\uff0c\u7b2c1\u7248\uff0c\u5317\u4eac\uff1a\u4eba\u6c11\u536b\u751f\u51fa\u7248\u793e\uff0c2011\u5e7410\u6708.', u'\r\n', u'7.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71.\xa0\u63a7\u5236\u56fe.\xa0\u89c1\uff1a\u7f57\u65ed\uff0c\u6bd5\u5f00\u987a\u4e3b\u7f16\uff0c\u533b\u836f\u7edf\u8ba1\u5b66\uff0c\u7b2c1\u7248\uff0c\u5317\u4eac\uff1a\u9ad8\u7b49\u6559\u80b2\u51fa\u7248\u793e\uff0c2010.\xa0 (\u666e\u901a\u9ad8\u7b49\u6559\u80b2\u201c\u5341\u4e00\u4e94\u201d\u56fd\u5bb6\u7ea7\u89c4\u5212\u6559\u6750)', u'\r\n', u'8.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71.\xa0\u624b\u6027\u9ad8\u6548\u6db2\u76f8\u8272\u8c31\u6cd5.\xa0\u89c1\uff1a\u59da\u5f64\u709c\u4e3b\u7f16\uff0c\u624b\u6027\u836f\u7269\u5206\u6790\uff0c\u7b2c1\u7248\uff0c\u5317\u4eac\uff1a\u4eba\u6c11\u536b\u751f\u51fa\u7248\u793e\uff0c2008.', u'\r\n', u'9.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u4f59\u9732\u5c71(\u526f\u4e3b\u7f16).\xa0\u836f\u7269\u4ee3\u8c22\u5b9e\u9a8c\u548c\u6280\u672f.\xa0\u89c1\uff1a\u66fe\u82cf\u4e3b\u7f16\uff0c\u836f\u7269\u4ee3\u8c22\u5b66\uff0c\u7b2c2\u7248\uff0c\u676d\u5dde\uff1a\u6d59\u6c5f\u5927\u5b66\u51fa\u7248\u793e\uff0c2008. (\u536b\u751f\u90e8\u201c\u5341\u4e8c\u4e94\u201d\u89c4\u5212\u6559\u6750)', u'\r\n', u'\xa0', u'\r\n', u'\u79d1\u7814\u9879\u76ee', u'\r\n', u'1.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1\uff08\u4e3b\u6301\uff09\u5434\u8331\u8438\u751f\u7269\u78b1\u7ecfCAR\u8c03\u8282\u7cd6\u8102\u4ee3\u8c22\u7684\u673a\u5236\u53ca\u5176PD/PK\u7814\u7a76\uff0881373475\uff092014', u'\r\n', u'2.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u94b1\u6c5f\u4eba\u624d\u8ba1\u5212\uff08\u4e3b\u6301\uff09\u5434\u8331\u8438\u751f\u7269\u78b1\u964d\u8840\u8102\u4f5c\u7528\u7684\u673a\u5236\u7814\u7a76\uff082013R10046\uff092013', u'\r\n', u'3.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u7701\u81ea\u7136\u79d1\u5b66\u57fa\u91d1\uff08\u4e3b\u6301\uff09\u4e94\u5473\u5b50\u8c03\u63a7UDP-\u8461\u8404\u7cd6\u919b\u9178\u8f6c\u79fb\u91761A1\u8868\u8fbe\u7684\u673a\u5236\u7814\u7a76\uff08J20120479\uff092012', u'\r\n', u'4.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u201c\u4e34\u5e8a\u524d\u836f\u7269\u4ee3\u8c22\u52a8\u529b\u5b66\u6280\u672f\u5e73\u53f0\u201d\u5b50\u9879\u76ee(2009ZX09304-3), \u8d1f\u8d23\uff0c2009', u'\r\n', u'5.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u201c\u65b0\u578b\u6297\u65e9\u8001\u6027\u75f4\u5446\u5019\u9009\u836fBYYT-25\u7684\u4e34\u5e8a\u524d\u8bc4\u4ef7\u201d\u5b50\u9879\u76ee\uff082009ZX09103-126\uff09\u8d1f\u8d23\uff0c2009', u'\r\n', u'6.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'863\u6d77\u6d0b\u4e13\u9879\u57fa\u91d1\uff08\u7b2c\u4e09\uff09\u65e0\u4f9d\u8d56\u6027\u6212\u6bd2\u521b\u65b0\u836f\u7269TTX\u7684\u4e34\u5e8a\u524d\u7814\u7a76 2007', u'\r\n', u'7.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1\uff08\u7b2c\u4e8c\uff09\u624b\u6027\u836f\u7269-\u805a\u5408\u7269\u7ed9\u836f\u7cfb\u7edf\u4e2d\u5bf9\u6620\u4f53\u9009\u62e9\u6027\u4f53\u5185\u5916\u91ca\u653e\u7684\u673a\u7406\u63a2\u7d22\uff0830772610\uff09\xa02008', u'\r\n', u'8.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1\uff08\u7b2c\u4e8c\uff09 UGT\u53d8\u5f02\u4f53\u4ecb\u5bfc\u7684\u8461\u919b\u9178\u7ed3\u5408\u53cd\u5e94\u7684\u5bf9\u6620\u4f53\u9009\u62e9\u6027\u7814\u7a76\uff0830701038\uff092008', u'\r\n', u'9.', u'\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 ', u'\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1\u4f50\u7c73\u66f2\u5766\u6027\u522b\u5dee\u5f02\u6027\u8bf1\u5bfc\u5927\u9f20\u809dCYP3A\u7684\u673a\u7406\uff0830600772\uff0c\u4e3b\u6301\uff09 2007', u'\r\n', u'10.', u'\xa0\xa0\xa0\xa0 ', u'\u6d59\u6c5f\u5927\u5b66\u4f18\u79c0\u9752\u5e74\u6559\u5e08\u8d44\u52a9\u8ba1\u5212\u201c\u7d2b\u91d1\u8ba1\u5212\u201d\uff08\u4e3b\u6301\uff092006', u'\r\n', u'11.', u'\xa0\xa0\xa0\xa0 ', u'\u4e2d\u56fd\u535a\u58eb\u540e\u57fa\u91d1\u4e8c\u7b49\u8d44\u52a9\uff0820060391065\uff0c\u4e3b\u6301\uff092006', u'\r\n', u'12.', u'\xa0\xa0\xa0\xa0 ', u'\u4f01\u4e1a\u9879\u76ee\xa0\xa0 \uff08\u8d1f\u8d23\uff09\u4e00\u7c7b\u65b0\u836fHZZ112\u4e34\u5e8a\u524d\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\uff0c2013', u'\r\n', u'13.', u'\xa0\xa0\xa0\xa0 ', u'\u4f01\u4e1a\u9879\u76ee\xa0\xa0 \uff08\u8d1f\u8d23\uff09\u5c3c\u83ab\u5730\u5e73\u8102\u80aa\u4e73\u6ce8\u5c04\u6db2\u6ce8\u5c04\u6db2\u7684\u4e34\u5e8a\u524d\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\uff0c2012', u'\r\n', u'14.', u'\xa0\xa0\xa0\xa0 ', u'\u4f01\u4e1a\u9879\u76ee\xa0\xa0 \uff08\u8d1f\u8d23\uff09\u4e00\u7c7b\u65b0\u836fCMS-\u2160\u7684\u4e34\u5e8a\u524d\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\uff0c2011', u'\r\n', u'15.', u'\xa0\xa0\xa0\xa0 ', u'\u4f01\u4e1a\u9879\u76ee\xa0\xa0 \uff08\u8d1f\u8d23\uff09\u4e00\u7c7b\u65b0\u836fAC-8\u4e34\u5e8a\u524d\u836f\u6548\u5b66\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\uff0c2011', u'\r\n', u'16.', u'\xa0\xa0\xa0\xa0 ', u'\u4f01\u4e1a\u9879\u76ee\xa0\xa0 \uff08\u8d1f\u8d23\uff09\u4e00\u7c7b\u65b0\u836f\u53c2\u828d\u964d\u8102\u7247\u4e34\u5e8a\u524d\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\uff0c2011', u'\r\n', u'17.', u'\xa0\xa0\xa0\xa0 ', u'\u4f01\u4e1a\u9879\u76ee\xa0\xa0 \uff08\u8d1f\u8d23\uff09N\u7cd6\u548c\u553e\u6db2\u9178\u542b\u91cf\u4e0d\u540c\u7684RCT-18\u7684\u4e34\u5e8a\u524d\u836f\u52a8\u5b66\u6bd4\u8f83\u7814\u7a76(H20100708)\uff0c2010', u'\r\n', u'18.', u'\xa0\xa0\xa0\xa0 ', u'\u4f01\u4e1a\u9879\u76ee\xa0\xa0 \uff08\u8d1f\u8d23\uff09\u4e00\u7c7b\u65b0\u836fRCT-18\u7684\u4e34\u5e8a\u524d\u836f\u7269\u52a8\u529b\u5b66\u7814\u7a76\xa02009', u'\r\n', u'19.', u'\xa0\xa0\xa0\xa0 ', u'\u4f01\u4e1a\u9879\u76ee\xa0\uff08\u8d1f\u8d23\uff09\u4e00\u7c7b\u65b0\u836fYN1\u7684\u4e34\u5e8a\u524d\u836f\u7269\u52a8\u529b\u5b66\u7814\u7a76\xa02009', u'\r\n', u'\xa0', u'\n\t\t\t', u'\n\t\t', u'        \t\t', u'\n\t\t\t', u'\u5de5\u4f5c\u7814\u7a76\u9886\u57df', u'\n\t\t\t', u'\n\t\t\t', u'\u624b\u6027\u836f\u7269\u8d28\u91cf\u63a7\u5236\u548c\u4ee3\u8c22\u76f8\u5173\u7814\u7a76\r\n\u836f\u7269\u4ee3\u8c22\u9176\u7684\u8c03\u8282\r\n\u4e34\u5e8a\u524d\u836f\u7269\u4ee3\u8c22\u52a8\u529b\u5b66\u7814\u7a76\uff08PK\uff09', u'\n\t\t\t', u'\n\t\t', u'        \t\t', u'\n\t\t\t', u'\u8054\u7cfb\u65b9\u5f0f', u'\n\t\t\t', u'\n\t\t\t\u7535\u8bdd\uff1a88208407', u'\t\t\t\u7535\u5b50\u4fe1\u7bb1\uff1ayuls@zju.edu.cn', u'\t\t\t', u'\n\t\t', u'\n        \t\t\t\n\t'], 'department': u'\uff1a\u6d59\u6c5f\u5927\u5b66\u836f\u7269\u7814\u7a76\u6240', 'homepage': 'http://mypage.zju.edu.cn/yuls'}
